Hepatitis C genotype 4: What we know and what we don't yet know
暂无分享,去创建一个
[1] S. Futagawa,et al. The Influence of Viral Genotypes and Rejection Episodes on the Recurrence of Hepatitis C After Liver Transplantation , 2003, Surgery Today.
[2] A. Zekry,et al. Steatosis and chronic hepatitis C virus infection: mechanisms and significance. , 2005, Clinics in liver disease.
[3] F. Mahoney,et al. Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. , 2003, American journal of infection control.
[4] A. el-Zayadi,et al. Response of Hepatitis C Genotype-4 Naïve Patients to 24 Weeks of Peg-Interferon-α2b/Ribavirin or Induction-Dose Interferon-α2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study , 2005, The American Journal of Gastroenterology.
[5] A. Bener,et al. Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: impact of bilharziasis and fibrosis stage. , 2006, World journal of gastroenterology.
[6] N. Afdhal,et al. Duration of peginterferon therapy in acute hepatitis C: A randomized trial , 2006, Hepatology.
[7] M. Buti,et al. Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. , 2006, Journal of hepatology.
[8] T. Therneau,et al. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. , 1996, The American journal of gastroenterology.
[9] G. Alexander,et al. Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type? , 2007, Journal of viral hepatitis.
[10] C. Bréchot,et al. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. , 2000, Annals of internal medicine.
[11] T. Nakano,et al. Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients , 2004, Journal of Virology.
[12] M. Massari,et al. Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] P. Angus,et al. Liver transplantation for HCV‐associated liver cirrhosis: Predictors of outcomes in a population with significant genotype 3 and 4 distribution , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] M. Abdel-hamid,et al. Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalence , 2000, Hepatology.
[15] L. Bianchi,et al. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. , 2004, Journal of Infectious Diseases.
[16] P. Simmonds,et al. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. , 1995, The Journal of general virology.
[17] T. Hassanein,et al. Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin. , 2004, Annals of internal medicine.
[18] G. Mancia,et al. HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients. , 1998, Journal of hepatology.
[19] Todd M. Allen,et al. Characterization of full‐length hepatitis C virus genotype 4 sequences , 2007, Journal of viral hepatitis.
[20] L. Bianchi,et al. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. , 2000, Liver.
[21] J. López-Siles,et al. High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): Phylogenetic and epidemiological analyses , 2006, Journal of medical virology.
[22] L. Magder,et al. Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data. , 2004, International journal of epidemiology.
[23] S. Labeeb,et al. Informal health providers and the transmission of hepatitis C virus: pilot study in two Egyptian villages. , 2006, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[24] J. Desenclos,et al. Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[25] F. Thakeb,et al. 252 Randomized controlled trial of PEGinterferon alfa-2A plus ribavirin for chronic hepatitis C virus-genotype 4 among Egyptian patients , 2003 .
[26] F. Callea,et al. Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. , 1997, Journal of hepatology.
[27] Z. Goodman,et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. , 2001, Journal of hepatology.
[28] E. Tsochatzis,et al. Hepatic Steatosis in Genotype 4 Chronic Hepatitis C Is Mainly Because of Metabolic Factors , 2007, The American Journal of Gastroenterology.
[29] J. Ghrayeb,et al. Memory CD8+ T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection , 2003, The Journal of experimental medicine.
[30] M. Abdel-hamid,et al. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. , 2007, The Journal of general virology.
[31] B. Gunson,et al. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4 , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[32] S. Salmaso,et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy , 2005, Journal of medical virology.
[33] S. El-Kamary,et al. Changing patterns of acute viral hepatitis at a major urban referral center in Egypt. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] F. Shebl,et al. Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[35] B. Walker,et al. Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.
[36] P. Simmonds,et al. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. , 1997, The Journal of general virology.
[37] G. Lachenal,et al. The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[38] S. Kashiwagi,et al. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection. , 1996, Journal of the National Cancer Institute.
[39] L. Seeff,et al. Natural history of chronic hepatitis C , 2002, Hepatology.
[40] B. Bacon,et al. Infection with Hepatitis C Virus Genotype 4 in the United States , 2004, Journal of clinical gastroenterology.
[41] K. Batts,et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. , 1997, Transplantation.
[42] L. Skakni,et al. Hepatitis C genotypes and subtypes in Saudi Arabia , 1999, Journal of medical virology.
[43] A. Alberti,et al. Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features , 1998, Gut.
[44] V. de Lédinghen,et al. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection , 2007, Journal of viral hepatitis.
[45] T. Nakano,et al. Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response , 2005, Gut.
[46] Takanobu Kato,et al. Exponential Spread of Hepatitis C Virus Genotype 4a in Egypt , 2004, Journal of Molecular Evolution.
[47] B. Clotet,et al. Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1. , 2007, Virus research.
[48] S. Kamal,et al. Interferon therapy in patients with chronic hepatitis C and schistosomiasis. , 2000, Journal of hepatology.
[49] L. Magder,et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt , 2000, The Lancet.
[50] L. Magder,et al. Intrafamilial transmission of hepatitis C in Egypt , 2005, Hepatology.
[51] Christophe Combet,et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes , 2005, Hepatology.
[52] E. Keeffe,et al. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[53] E. Holmes,et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. , 1993, The Journal of general virology.
[54] M. Rapicetta,et al. Molecular heterogeneity and new subtypes of HCV genotype 4. , 1998, Research in virology.
[55] E. Delaporte,et al. Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). , 1994, The Journal of general virology.
[56] L. Bianchi,et al. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response. , 2001, Gastroenterology.
[57] Gamal Esmat,et al. Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. , 2007, Journal of hepatology.
[58] L. Bianchi,et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis , 2006, Hepatology.
[59] M. Sherman,et al. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. , 2001, Annals of internal medicine.
[60] O. Pybus,et al. Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. , 2003, The Journal of general virology.
[61] R. Fontana,et al. Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[62] M. Khuroo,et al. Meta‐analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4 , 2004, Alimentary pharmacology & therapeutics.
[63] P. Simmonds,et al. Genetic diversity and evolution of hepatitis C virus--15 years on. , 2004, The Journal of general virology.
[64] M. Hashem,et al. Pegylated interferon alpha‐2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response , 2007, Hepatology.
[65] M. Mondelli,et al. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: A seventeen‐year prospective cohort study , 2007, Hepatology.
[66] P. Simmonds,et al. The origin of hepatitis C virus genotypes. , 1997, The Journal of general virology.
[67] M. Pinzani,et al. Progression of fibrosis in chronic liver diseases: time to tally the score. , 2001, Journal of hepatology.
[68] I. Siddique,et al. Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C Genotype 4 , 2004, American Journal of Gastroenterology.
[69] K. Reddy,et al. Hepatitis C Virus Genotypes in the United States: Epidemiology, Pathogenicity, and Response to Interferon Therapy , 1996, Annals of Internal Medicine.
[70] H. J. Hnatyszyn,et al. Chronic Hepatitis C and Genotyping: The Clinical Significance of Determining HCV Genotypes , 2005, Antiviral therapy.
[71] V. Soriano,et al. Response to Interferon-Based Therapies in HIV-Infected Patients with Chronic Hepatitis C Due to Genotype 4 , 2005, Antiviral therapy.
[72] C. Pasquier,et al. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. , 2005, The Journal of general virology.
[73] D L Thomas,et al. Genetic epidemiology of hepatitis C virus throughout egypt. , 2000, The Journal of infectious diseases.
[74] J. Izopet,et al. Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection , 2005, Journal of medical virology.
[75] M. Rapicetta,et al. Molecular Epidemiology of Hepatitis C Virus Genotype 4 Isolates in Egypt and Analysis of the Variability of Envelope Proteins E1 and E2 in Patients with Chronic Hepatitis , 2005, Journal of Clinical Microbiology.
[76] J. Wong,et al. Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium. , 2002, Acta gastro-enterologica Belgica.
[77] A. Lonardo,et al. Hepatitis C and steatosis: a reappraisal , 2006, Journal of viral hepatitis.
[78] T. Gojobori,et al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization , 1998, Archives of Virology.
[79] P. Marcellin,et al. Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis. , 2000, Liver.
[80] A. el-Zayadi,et al. Non-alcoholic fatty liver disease in patients with HCV genotype 4 , 2007, Gut.
[81] V. Soriano,et al. Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases. , 2007, AIDS research and human retroviruses.
[82] T. Asselah,et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. , 2006, Gastroenterology.
[83] J. Kaldor,et al. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies , 2006, Journal of viral hepatitis.
[84] M. Buti,et al. A cost‐effectiveness analysis of peginterferon alfa‐2b plus ribavirin for the treatment of naive patients with chronic hepatitis C , 2003, Alimentary pharmacology & therapeutics.
[85] P. Couzigou,et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study , 2005, Journal of viral hepatitis.
[86] E. Holmes,et al. Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. , 1993, The Journal of general virology.
[87] Md. Parvez Anwar,et al. 324 Results of a randomized clinical trial of genotype-4 infected subjects when treated with standard or pegylated interferon alfa-2B in combination with ribavirin , 2003 .
[88] L. Magder,et al. Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity , 2001, Hepatology.
[89] A. García-Sánchez,et al. Clinical and Pathological Characteristics and Response to Combination Therapy of Genotype 4 Chronic Hepatitis C Patients: Experience from a Spanish Center , 2007, Journal of chemotherapy.
[90] G. Magiorkinis,et al. Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype‐specific incidence and molecular characterization of genotype 4 isolates , 2006, Journal of viral hepatitis.
[91] Tamer Hifnawy,et al. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. , 2005, International journal of hygiene and environmental health.
[92] O. Pybus,et al. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. , 2003, Molecular biology and evolution.
[93] M. Al-Ahdal,et al. Peginterferon α‐2b plus ribavirin compared with interferon α‐2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4 , 2004, Liver international : official journal of the International Association for the Study of the Liver.